药品名称CENESTIN
申请号020992产品号001
活性成分ESTROGENS, CONJUGATED SYNTHETIC A市场状态停止上市
剂型或给药途径TABLET;ORAL规格0.3MG
治疗等效代码参比药物
批准日期2002/06/21申请机构TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC
化学类型New dosage form审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
59086382015/07/26YPDF格式
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
020992034APLetter2015/03/24下载
020992034APLabel2015/03/24下载
020992026APLetter2004/10/29下载
020992026APLabel2004/11/01下载
020992024APLetter2004/02/02下载
020992021APLetter2004/03/03下载
020992021APLabel2004/04/05下载
020992016APReview2007/06/18下载
020992016APLetter2002/06/21下载
020992016APLabel2002/06/21下载
020992011APLetter2002/02/22下载
020992000APLetter1999/03/24下载
020992000APReview1999/03/24下载
020992000APLabel1999/03/24下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
020992034AP2015/03/20Labeling Revision
020992026AP2004/10/28Labeling Revision
020992024AP2004/01/28Labeling Revision
020992023AP2002/11/05Control Supplement
020992022AP2002/10/18Manufacturing Change or Addition
020992021AP2004/02/05New Dosage Regimen
020992020AP2002/04/29Manufacturing Change or Addition
020992019AP2002/03/05Control Supplement
020992018AP2002/02/08Control Supplement
020992017AP2002/02/08Control Supplement
020992016AP2002/06/21New or Modified Indication
020992015AP2001/09/05Control Supplement
020992014AP2001/09/10Control Supplement
020992013AP2001/09/05Control Supplement
020992012AP2001/07/20Manufacturing Change or Addition
020992011AP2002/02/22Labeling Revision
020992009AP2000/08/09Control Supplement
020992007AP2000/01/27Manufacturing Change or Addition
020992006AP2000/03/13Formulation Revision
020992005AP2000/01/07Control Supplement
020992004AP1999/11/08Control Supplement
020992003AP1999/11/12Control Supplement
020992002AP1999/11/02Package Change
020992001AP1999/09/07Control Supplement
020992000AP1999/03/24Approval